IT8848690A0 - Forma cristallina della ciclosporina, la sua preparazione e composizioni farmaceutiche che la comprendono - Google Patents

Forma cristallina della ciclosporina, la sua preparazione e composizioni farmaceutiche che la comprendono

Info

Publication number
IT8848690A0
IT8848690A0 IT8848690A IT4869088A IT8848690A0 IT 8848690 A0 IT8848690 A0 IT 8848690A0 IT 8848690 A IT8848690 A IT 8848690A IT 4869088 A IT4869088 A IT 4869088A IT 8848690 A0 IT8848690 A0 IT 8848690A0
Authority
IT
Italy
Prior art keywords
cyclosporine
preparation
pharmaceutical compositions
crystalline form
crystalline
Prior art date
Application number
IT8848690A
Other languages
English (en)
Other versions
IT1235356B (it
Inventor
Giron Danielle
List Martin
Richter Friederich
Weber Hans Peter
Yasuyuki Uike
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8848690A0 publication Critical patent/IT8848690A0/it
Application granted granted Critical
Publication of IT1235356B publication Critical patent/IT1235356B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IT8848690A 1987-12-21 1988-12-20 Forma cristallina della ciclosporina, la sua preparazione e composizioni farmaceutiche che la contengono IT1235356B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (2)

Publication Number Publication Date
IT8848690A0 true IT8848690A0 (it) 1988-12-20
IT1235356B IT1235356B (it) 1992-06-30

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848690A IT1235356B (it) 1987-12-21 1988-12-20 Forma cristallina della ciclosporina, la sua preparazione e composizioni farmaceutiche che la contengono

Country Status (27)

Country Link
JP (1) JPH0791316B2 (it)
KR (1) KR100188305B1 (it)
AT (1) AT403163B (it)
AU (1) AU626274B2 (it)
BE (1) BE1002665A4 (it)
CA (1) CA1341396C (it)
CH (1) CH677926A5 (it)
CY (1) CY1799A (it)
DE (1) DE3843054C2 (it)
DK (1) DK175220B1 (it)
ES (1) ES2012580A6 (it)
FI (1) FI89065C (it)
FR (1) FR2624863B1 (it)
GB (1) GB2211848B (it)
GR (1) GR1002486B (it)
HK (1) HK102894A (it)
HU (1) HU203564B (it)
IE (1) IE62006B1 (it)
IL (1) IL88719A0 (it)
IT (1) IT1235356B (it)
LU (1) LU87409A1 (it)
MY (1) MY103943A (it)
NL (1) NL195096C (it)
NO (1) NO177228C (it)
NZ (1) NZ227384A (it)
SE (1) SE503174C2 (it)
SG (1) SG99494G (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
WO1993023010A1 (en) * 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
JP2000516256A (ja) 1997-01-30 2000-12-05 ノバルティス アクチエンゲゼルシャフト サイクロスポリンaを含む無油医薬組成物
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
ES2318453T3 (es) 2004-01-20 2009-05-01 Allergan, Inc. Composiciones para terapia localizada del ojo, que comprenden, de preferencia,triamcinolona acetonida y acido hialuronico.
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
BR112013030554B1 (pt) * 2011-05-27 2020-12-15 Allergan, Inc. Forma cristalina de ciclosporina a, métodos de preparação e métodos para uso da mesma
CN104039813B (zh) * 2011-11-15 2017-08-29 阿勒根公司 环孢菌素a形式2及其制备方法
CA2856074C (en) * 2011-11-15 2017-07-04 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
CA2856044C (en) 2011-11-15 2016-11-29 Allergan, Inc. Sustained action formulation of cyclosporin form 2
AU2012339632A1 (en) 2011-11-15 2014-06-05 Allergan, Inc. Suspensions of cyclosporin A Form 2
EP4585605A1 (en) * 2022-10-20 2025-07-16 Chugai Seiyaku Kabushiki Kaisha Method for producing cyclic peptide crystals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (it) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
FI885869A0 (fi) 1988-12-19
GR1002486B (el) 1996-12-09
CY1799A (en) 1995-02-17
GR880100850A (el) 1994-03-31
CA1341396C (en) 2002-11-05
DK705488D0 (da) 1988-12-19
NO177228C (no) 1995-08-09
BE1002665A4 (fr) 1991-04-30
GB2211848A (en) 1989-07-12
KR100188305B1 (ko) 1999-06-01
NO177228B (no) 1995-05-02
NO885625D0 (no) 1988-12-19
ES2012580A6 (es) 1990-04-01
SE8804570D0 (sv) 1988-12-19
IE62006B1 (en) 1994-12-14
GB2211848B (en) 1991-11-06
IE883779L (en) 1989-06-21
JPH0791316B2 (ja) 1995-10-04
NL8803125A (nl) 1989-07-17
HK102894A (en) 1994-09-30
SE503174C2 (sv) 1996-04-15
FR2624863A1 (fr) 1989-06-23
ATA309588A (de) 1997-04-15
FI89065C (fi) 1993-09-30
SG99494G (en) 1994-10-28
FI885869L (fi) 1989-06-22
FI89065B (fi) 1993-04-30
HU203564B (en) 1991-08-28
CH677926A5 (it) 1991-07-15
DK175220B1 (da) 2004-07-12
AU2705588A (en) 1989-06-22
JPH01211598A (ja) 1989-08-24
DK705488A (da) 1989-06-22
NO885625L (no) 1989-06-22
NZ227384A (en) 1991-09-25
AT403163B (de) 1997-11-25
HUT49893A (en) 1989-11-28
GB8829556D0 (en) 1989-02-08
IT1235356B (it) 1992-06-30
FR2624863B1 (fr) 1991-04-26
DE3843054A1 (de) 1989-07-27
LU87409A1 (fr) 1989-07-07
SE8804570L (sv) 1989-06-22
IL88719A0 (en) 1989-07-31
DE3843054C2 (de) 2003-08-21
AU626274B2 (en) 1992-07-30
KR890009975A (ko) 1989-08-05
NL195096C (nl) 2004-02-09
MY103943A (en) 1993-10-30

Similar Documents

Publication Publication Date Title
IT8848690A0 (it) Forma cristallina della ciclosporina, la sua preparazione e composizioni farmaceutiche che la comprendono
DK89090D0 (da) Farmaceutisk praeparat
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
IT1240605B (it) Composizione farmaceutica solida e procedimento per la sua preparazione
DK489189D0 (da) Farmaceutisk praeparat
TR24553A (tr) Granueler halinde fosfor icermiyen agartma-maddesi ni aktiflestirici bilesimleri
IT8222768A0 (it) Alcaloidi peptidici della segale cornuta, loro preparazione e composizioni farmaceutiche che licontengono.
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
IT1226586B (it) Composizioni farmaceutiche che favoriscono la cicatrizzazione di ferite e procedimento per prepararle
MC1878A1 (fr) Compositions pharmaceutiques
DK603988D0 (da) Farmaceutisk praeparat
IT8819835A0 (it) Composizione dietetica eprocedimento per la sua preparazione.
FI884750A7 (fi) Shampookoostumuksia
DK139388A (da) Farmaceutisk praeparat
ITMI912002A1 (it) Composizione farmaceutica solida e procedimento per la sua preparazione
IT1208416B (it) Preparato di sucralfato e procedimento per la sua produzione
IT1204306B (it) (-)-1beta-etil-1alfa-idrossimentil-1,2,3,4,6,7,12,12balfa-ottaidroindolo (2,3-a)chinolizina,procedimento per la sua preparazione e composizioni farmaceutiche che la contengono
MX11584A (es) Composiciones farmaceuticas
IT8548964A0 (it) 8alfa-acilamminoergoline,loro preparazione e composizioni farmaceutiche che le contengono
BR9006025A (pt) Preparacao farmaceutica
IT8721958A0 (it) Derivato di taurina, sua preparazione e composizioni farmaceutiche relative
IT8747977A0 (it) Composizioni farmaceutiche
FI881648L (fi) Shampookoostumuksia
BR8807102A (pt) Preparacao de novos adocantes de proteina

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971205